Skip to content
6-K

Foreign Interim / Material

Abivax S.A. AAVXF ABVX

0001956827-25-000035

← back to feed
Filed
Dec 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 72.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 66.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 63.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 63.02M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −€137.9M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −€120.56M
Cash And Equivalents Q3 2025 · Sep 30, 2025 €589.7M
Cash And Equivalents Q3 2025 · Dec 31, 2024 €144.22M
Cash And Equivalents Q3 2025 · Sep 30, 2024 €180.45M
Cash And Equivalents Q3 2025 · Dec 31, 2023 €251.94M
Stockholders Equity Q3 2025 · Sep 30, 2025 €511.24M
Stockholders Equity Q3 2025 · Dec 31, 2024 €40.58M
Stockholders Equity Q3 2025 · Sep 30, 2024 €75.88M
Stockholders Equity Q3 2025 · Dec 31, 2023 €196.01M
Current Liabilities Q3 2025 · Sep 30, 2025 €78.76M
Current Liabilities Q3 2025 · Dec 31, 2024 €94M
Current Assets Q3 2025 · Sep 30, 2025 €619.3M
Current Assets Q3 2025 · Dec 31, 2024 €170.67M
Total Assets Q3 2025 · Sep 30, 2025 €652.05M
Total Assets Q3 2025 · Dec 31, 2024 €205.23M
Eps Diluted Q3 2025 · Sep 30, 2025 −€2.10
Eps Diluted Q3 2025 · Sep 30, 2025 −€3.81
Eps Diluted Q3 2025 · Sep 30, 2024 −€0.87
Eps Diluted Q3 2025 · Sep 30, 2024 −€2.17
Eps Basic Q3 2025 · Sep 30, 2025 −€2.10
Eps Basic Q3 2025 · Sep 30, 2025 −€3.81
Eps Basic Q3 2025 · Sep 30, 2024 −€0.87
Eps Basic Q3 2025 · Sep 30, 2024 −€2.17
Rd Expense Q3 2025 · Sep 30, 2025 €55.42M
Rd Expense Q3 2025 · Sep 30, 2025 €133.36M
Rd Expense Q3 2025 · Sep 30, 2024 €43.29M
Rd Expense Q3 2025 · Sep 30, 2024 €107.94M
Net Income Q3 2025 · Sep 30, 2025 −€153.36M
Net Income Q3 2025 · Sep 30, 2025 −€254.14M
Net Income Q3 2025 · Sep 30, 2024 −€55.23M
Net Income Q3 2025 · Sep 30, 2024 −€136.86M
Operating Income Q3 2025 · Sep 30, 2025 −€80.71M
Operating Income Q3 2025 · Sep 30, 2025 −€174.41M
Operating Income Q3 2025 · Sep 30, 2024 −€50.19M
Operating Income Q3 2025 · Sep 30, 2024 −€130.19M